MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
CABA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cabaletta Bio (CABA) Earnings Date & Reports

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases... Show more

A.I. Advisor
published Earnings

CABA is expected to report earnings to -65 cents per share on May 29

Cabaletta Bio CABA Stock Earnings Reports
Q1'25
Est.
$-0.66
Q4'24
Missed
by $0.01
Q3'24
Missed
by $0.02
Q2'24
Missed
by $0.01
Q1'24
Missed
by $0.03
The last earnings report on March 31 showed earnings per share of -64 cents, missing the estimate of -63 cents. With 1.57M shares outstanding, the current market capitalization sits at 110.87M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Earnings TradersEarnings Traders
Annualized Return+24%
VIEW DETAILSVIEW DETAILS
VIEW FOR FREEVIEW FOR FREE
CABA
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View Trends For CABA
(Try 14 days for Free)
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2929 Arch Street
Phone
+1 267 759-3100
Employees
103
Web
https://www.cabalettabio.com